alternative to semaglutide FDA Approves Oral as the First Oral GLP-1 Pill FDA cracks down on weight-loss

Peptide Dossier

Slows digestion: It delays gastric emptying, slowing sugar absorption and making you feel full longer

However, genetic predisposition is not deterministic of exact medication response

On the latter, studies conducted using site-specific brain micro-injections and single-photon emission computed tomography documented a novel regulatory role of the hypothalamic supramammillary nucleus in the regulation of food intake and reward, posing this brain area as one of the main targets of the GLP1/E conjugate, along with the lateral hypothalamus and the nucleus of the solitary tract, whose activation may be responsible for the anorectic, weight-lowering and reward reducing effects of this multi-agonist 51

doi: 10.1016/j.jff.2023.105921 380 DraganescuDAndritoiuCHritcuDDodiGPopaMI